ClinicalTrials.gg
Sign In
Enrolling by invitationNCT07157917SEDEUpdated Apr 13, 2026

Thirst Translation and RCT

An interventional study of Protocol based and Control in Thirst in Intensive Care Unit (ICU) Practice, sponsored by National Taiwan University. Enrolling by invitation at 1 site in Taiwan. Open to participants aged 18 Years to 100 Years. Per ClinicalTrials.gov, last updated 2026-04-13.

Sponsored by National Taiwan University · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
18 Years to 100 Years
Sex
All
01

Study summary

To translate the SEDE-E (Extubated) and SEDE-T(tracheotomized) protocols-Chinese version and validate it with an RCT trial

02

Conditions studied

  • Thirst in Intensive Care Unit (ICU) Practice

Keywords

  • Thirst
03

In context

Lead sponsor

National Taiwan University is the lead sponsor of 22 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 100 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Patients whose physicians have issued orders for removal of the endotracheal tube or who have undergone tracheotomy,
  2. patients with clear consciousness
  3. patients who can communicate in Chinese as their native language

Exclusion criteria

Exclusion Criteria:

  1. patients with water restriction
  2. patients who have undergone thirst quenching intervention measurements in the recovery room.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
120 participants (estimated)

Study arms

  • Experimental
    SEDE Group

    Intervene with a thirst management protocol

    Other: Protocol based

  • Placebo comparator
    Usual care control

    Room temperature water if needed

    Other: Control

Interventions

  • OtherProtocol based

    Apply a thirst safety management protocol

  • OtherControl

    Room air water

06

What researchers measure

Primary outcomes

  1. Thirst intensity visual analogue scales

    This is a 0\~10 point Likert scale, with 0 indicates no thirsty, and 10 indicates the most severe thirsty.

    Time frame: 0, 15, 60 minutes

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No — Patient private consideration

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 13, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07157917
Lead sponsor
National Taiwan University
Collaborators
National Taiwan University Hospital
Responsible party
Han-Yi Tsai (Taipei Medical University, School of Nursing, College of Nursing, Taipei Medical University) — Principal investigator
First posted
Sep 5, 2025
Start date
Apr 1, 2026
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Apr 13, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

National Taiwan University

Start the discussion